Additionally, STAT3 inhibition attenuates resistance to anticancer chemo- and radiotherapy.7 Furthermore, STAT3 inhibition prevents the transition of normal cells into tumor cells making this oncogenic protein an attractive target for cancer drug discovery.8–10. The gene discussed is STAT3; the disease is neoplasm.